Replies to post #31671 on NorthWest Biotherapeutics Inc (NWBO)

[iclight]

If only the FDA based P3 success on your common sense and not actual numbers, you know, the analyticals you a thumbing your nose at.

[Dan88]

Not all, at least maybe you should exclude me from that group. I, an immigrant, earned a Ph.D. in engineering in an "Ivy," and have worked dozens of years in various sectors, including industry, academics, and even a lawyer firm.

But don't challenge me with an English contest!

Anyhow and anyway (do those two words the most hated in the world?), cheer for today's great results and your mostly true analysis and observation.

We are heading to higher land, and we should leave plenty of time for market to respond!

[duderaja]

I also had a business for 22 and retired at age 53. I had numerous such work for me (a high school grad)and one of them had a PhD but couldn't find his butt with both hands and remained working at the same dead end job 21 years after I sold the place. The guy I sold it to had a PHD too and the business dropped 20% the first year he had it while I grew the business every year I owned it. Not saying every phd is like this.

[longusa]

Hi Jeff, the reason for the focus on understanding the analytics is that the FDA/PEI/MHRA are made up of analytic personalities and all use the stat analysis to make the approval decisions.

I agree common sense says DCVax works and works extremely well by historical standards, but the stat analysis must back it up for NW and DCVax to be successful.

IMO any individual stock biotech investor is well served to acquire at least a rudimentary understanding of how the analysis is done (and what the analysis results are for a given treatment) when a BLA/NDA is submitted.